Erlotinib Hydrochloride from Japan
Erlotinib hydrochloride is an epidermal growth factor receptor (EGFR) inhibitor used in non-small cell lung cancer treatment. As a quinazoline derivative (aromatic heterocycle with nitrogen), it qualifies under HTS 2933.99.75.00 for aromatic heterocyclic drugs.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include FDA IND/ANDA documentation and stability data for API import
• Verify polymorphic form and particle size specifications match DMF
• Label shipments clearly as 'Bulk Drug Substance - Rx Only' to prevent retail misclassification